(Q43623821)

25 November 2017

A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users (English)

1 reference

randomized controlled trial

25 November 2017

1 reference

1 reference

0 references

Chaisson RE

1

1 reference

25 November 2017

Barnes GL

2

1 reference

25 November 2017

Hackman J

3

1 reference

25 November 2017

Watkinson L

4

1 reference

25 November 2017

Kimbrough L

5

1 reference

25 November 2017

Metha S

6

1 reference

25 November 2017

Cavalcante S

7

1 reference

25 November 2017

Moore RD

8

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

American Journal of Medicine

25 November 2017

1 reference

25 November 2017

110

1 reference

25 November 2017

8

1 reference

25 November 2017

610-615

1 reference

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

When tuberculosis treatment fails. A social behavioral account of patient adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Interventions for promoting adherence to tuberculosis management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Successful supervised ambulatory management of tuberculosis treatment failures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Eleven years of community-based directly observed therapy for tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Results of a directly observed intermittent isoniazid preventive therapy program in a shelter for homeless men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

A patient education program to improve adherence rates with antituberculosis drug regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Characteristics of controlled studies of patient education and counseling for preventive health behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

How often is medication taken as prescribed? A novel assessment technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Should we pay the patient? Review of financial incentives to enhance patient compliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Tuberculosis screening and compliance with return for skin test reading among active drug users.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2900695-7

10.1016/S0002-9343(01)00695-7

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference